[2-14C]Thymidine incorporation activity of stem cells in either tumor or cradle tissues in a normal or transplanted animals

  • Akiyo ShigematsuEmail author
  • Joji Yui
  • Yuko Hamai
  • Akiko Hatori

Summary A novel autoradiographic procedure was developed for such continuously cycling cells as stem cells on account of proliferating rate of which is astronomically high per min. Negative visualization is observed over any mitotic image by use of a biomarker, “[2-14C]thymidine” for a few minutes in both cases, either in vivo or in vitro systems. But, good visualization images were realized by many14C-β tracks over stem cells with a few minute labelling of [2-l4C]thymidine in originated cradles as predicted by Burkitt, H. G(1993). It is clearly elucidated that a short and quick labelling procedure of [2-14C]thymidine is useful to evaluate toxicity and efficacy of new drug candidates and to diagnose cluster of unknown malignity or proliferation rate of respective stem cell in in vivo or Ex-vivo system.

Results show that the cell proliferation rate of the stem cells in respective tissues was markedly suppressed, dependent on time after dosing and the dose of90Y; 3.7, 37, 370, 3, 700, and 37,000 kBq per mouse (25g). In addition to the above, the sensitivity of the proliferation rate was dependent on amitosis or mitosis and the AUC value of90Y-concentration at specific locations of the cells in the mouse body. The most sensitive cells were the plasmacytoma cells, followed by the pluripotent and unipotent stem cells, the intestinal crypts, epiphysial growth plate and liver cells. Results in this presentation, also gives a clear evidence showing a revival of facultative divider line from G0 stage of epithelium and mascular meditate into the unipotent stem cell cycle. Application of [2-14C]thymidine is useful for evaluation of a grade of maturation in differentiation of malignant cells or replicable unipotent stem cells. development of research in this area.


Biomarker [2-14C]thymidine stem cells in tumor stem cells in cradle tissues 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Chapter 2nd, Macroautoradiography, Autoradiography for Biologists (1972) edited by P. B. Gahan, Academic PressGoogle Scholar
  2. 2.
    Progressive application of autoradiography in pharmacokinetic and metabolic studies for the development of new drugs. (1995) J. Regul. Toxicol. Pharmacol. 22, 122–142.Google Scholar
  3. 3.
    Shigematsu, A., 1979 Microautoradiography. In: Mizuhira, V (Ed.), Autoradiography (Macro-, Micro-, and em). Ishiyaku Publisher, Japan (Chart V)Google Scholar
  4. 4.
    Barbara Young and John W. Heath (2000), Wheather's functional Histology, a text and colour atlas, 4th Ed., Churchill Livingstone Co., Ltd., London.Google Scholar
  5. 5.
    D. R. Marshak, R. L. Gardner, and D. Gottlieb (2001), “Stem Cell Biology”, Cold Spring Harbor Laboratory Press.Google Scholar
  6. 6.
    Shigematsu, A. et. al. (2004). Synchronous evaluation of toxico- and pharmaco- dynamics of yttrium-90by a novel autoradiographic procedure. Regulatory Toxicology and pharmacology 40,3, pp. 207–218.PubMedCrossRefGoogle Scholar
  7. 7.
    Y. Momose, Y. Mabuchi, A. Shigematsu, (1988). Autoradiographic characterization of newly developed metanoic cell group different from the melanoic tumor piece embedded into a liver of mice, European J. of Drug Meta. AndPharmcokinet. 13,4, pp 285–294CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2005

Authors and Affiliations

  • Akiyo Shigematsu
    • 1
    Email author
  • Joji Yui
    • 1
  • Yuko Hamai
    • 1
  • Akiko Hatori
    • 1
  1. 1.Institute of Whole Body MetabolismShiroi City, ChibaJapan

Personalised recommendations